您的位置: 首页 > 农业专利 > 详情页

COMPOUND, MEDICINAL PRODUCT¸ METHODS FOR INHIBITION OF GCN2 IN A MAMMALIAN AND FOR PROPHYLAXY OR TREATMENT OF CANCER IN A MAMMAL, AND USE OF COMPOUND OR A SALT THEREOF
专利权人:
TAKEDA PHARMACEUTICAL COMPANY LIMITED
发明人:
DOUGLAS ROBERT CARY,HIROSHI BANNO,JUN FUJIMOTO,OSAMU KURASAWA,TAKUTO KOJIMA,TERUFUMI TAKAGI,XIN LIU,YASUTOMI ASANO
申请号:
BR112019002576
公开号:
BR112019002576A2
申请日:
2017.08.09
申请国别(地区):
BR
年份:
2019
代理人:
摘要:
A heterocyclic compound which may have an inhibitory action on gcn2 is provided and is expected to be useful for the prophylaxis or treatment of gcn2-associated diseases, including cancer and the like. a compound represented by formula (i), wherein each symbol is as described in the specification, or a salt thereof.é fornecido um composto heterocíclico que pode ter uma ação inibitória para gcn2, e que se espera ser útil para a profilaxia ou tratamento de doenças associadas à gcn2, incluindo câncer e similares. um composto representado pela fórmula (i), em que cada símbolo é conforme descrito no relatório descritivo, ou um sal do mesmo.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充